2023
Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity
Franco I, Hoebeke P, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin P. Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity. Journal Of Urology 2023, 209: 774-784. PMID: 36655470, DOI: 10.1097/ju.0000000000003157.Peer-Reviewed Original ResearchConceptsTreatment-emergent adverse eventsNeurogenic detrusor overactivityUrinary tract infectionAdverse eventsSingle-treatment studyDetrusor overactivityTract infectionsSafety profileCommon treatment-emergent adverse eventsSerious treatment-emergent adverse eventsUrinary tract infection rateSimilar safety profileClean intermittent catheterizationNew safety concernsLong-term safetyAutonomic dysreflexiaIntermittent catheterizationMedian durationOnabotulinumtoxinA treatmentDistant spreadDose groupPediatric dataRepeat treatmentRepeated TreatmentPatients
2017
Imipramine for refractory daytime incontinence in the pediatric population
Franco I, Arlen AM, Collett-Gardere T, Zelkovic PF. Imipramine for refractory daytime incontinence in the pediatric population. Journal Of Pediatric Urology 2017, 14: 58.e1-58.e5. PMID: 29100969, DOI: 10.1016/j.jpurol.2017.08.016.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentChildChild, PreschoolCohort StudiesDatabases, FactualDiurnal EnuresisDose-Response Relationship, DrugDrug Administration ScheduleFemaleHumansImipramineLower Urinary Tract SymptomsMaleQuality of LifeRetrospective StudiesRisk AssessmentSeverity of Illness IndexTreatment OutcomeUrinary IncontinenceUrodynamicsConceptsVancouver Symptom ScorePercutaneous tibial nerve stimulationTranscutaneous electrical nerve stimulationInternational Children's Continence SocietyLower urinary tractSide effectsAlpha blockersDaytime incontinenceNerve stimulationTreatment responseParasacral transcutaneous electrical nerve stimulationNon-selective alpha blockersPartial response groupTreat response rateSubsequent clinic visitsTibial nerve stimulationElectrical nerve stimulationAdditional treatment modalitiesComplete treatment responseHalf of childrenYears of ageBowel programRefractory incontinenceUrology referralClinic visits
2001
Laparoscopic orchidopexy: a review of a large clinical series
Chang B, Palmer L, Franco I. Laparoscopic orchidopexy: a review of a large clinical series. BJU International 2001, 87: 490-493. PMID: 11298040, DOI: 10.1046/j.1464-410x.2001.00100.x.Peer-Reviewed Original ResearchMeSH KeywordsAmbulatory Surgical ProceduresChildChild, PreschoolCryptorchidismFollow-Up StudiesHumansInfantLaparoscopyMaleTestisTreatment OutcomeConceptsOverall success rateTesticular atrophyLaparoscopic proceduresPrevious testicular surgeryTesticular surgeryImpalpable testesSuccess rateAdditional dissectionLarge clinical seriesHigh overall success rateIntra-abdominal testesTwo-stage FPrevious surgeryMedian ageClinical seriesExtensive dissectionTesticular locationHigh riskPatientsAtrophySurgeryScrotumOrchidopexyInternal ringDissectionA multi‐institutional analysis of laparoscopic orchidopexy
Baker L, Docimo S, Surer I, Peters C, Cisek L, Diamond D, Caldamone A, Koyle M, Strand W, Moore R, Mevorach R, Brady J, Jordan G, Erhard M, Franco I. A multi‐institutional analysis of laparoscopic orchidopexy. BJU International 2001, 87: 484-489. PMID: 11298039, DOI: 10.1046/j.1464-410x.2001.00127.x.Peer-Reviewed Original ResearchConceptsLaparoscopic orchidopexyGroup 1Small seriesAtrophy ratesImpalpable testesOpen approachSuccess rateImpalpable undescended testicleOne-stage FowlerMulti-institutional analysisProcedure of choiceTwo-stage repairHigher atrophy ratesIntra-abdominal testesLack of atrophyTwo-stage FSatisfactory scrotal positionIntrascrotal positionUnrandomized studyClinical chartsSurgical groupLaparoscopic approachLaparoscopic examinationTherapeutic laparoscopyUndescended testicle
2000
ORAL CIMETIDINE FOR THE MANAGEMENT OF GENITAL AND PERIGENITAL WARTS IN CHILDREN
FRANCO I. ORAL CIMETIDINE FOR THE MANAGEMENT OF GENITAL AND PERIGENITAL WARTS IN CHILDREN. Journal Of Urology 2000, 164: 1074-1075. DOI: 10.1016/s0022-5347(05)67254-0.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralChild, PreschoolCimetidineCondylomata AcuminataFemaleHistamine H2 AntagonistsHumansMaleTreatment OutcomeConceptsExtensive condylomata acuminataFirst-line therapyPeptic ulcer diseaseHistamine receptor antagonistsTreatment of wartsUse of anesthesiaCimetidine dailyResultsAll patientsHerpes zosterLine therapyOral cimetidineAdjunctive treatmentMucocutaneous candidiasisUlcer diseaseCondylomata acuminataHerpes simplexImmunomodulatory effectsReceptor antagonistPrimary treatmentGenital areaHigh dosesCaustic agentsMultiple proceduresCimetidineMost wartsORAL CIMETIDINE FOR THE MANAGEMENT OF GENITAL AND PERIGENITAL WARTS IN CHILDREN
FRANCO I. ORAL CIMETIDINE FOR THE MANAGEMENT OF GENITAL AND PERIGENITAL WARTS IN CHILDREN. Journal Of Urology 2000, 164: 1074-1075. PMID: 10958744, DOI: 10.1097/00005392-200009020-00038.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralChild, PreschoolCimetidineCondylomata AcuminataFemaleHistamine H2 AntagonistsHumansMaleTreatment OutcomeConceptsTreatment of mucocutaneous candidiasisFree of condylomaTreated 4 childrenTreatment of condylomaDoses of cimetidineHistamine receptor antagonistsTreatment of wartsTreat peptic ulcer diseasePeptic ulcer diseaseMucocutaneous candidiasisOral cimetidineDivided dosesReceptor antagonistCondylomata acuminataHerpes simplexHerpes zosterPrimary treatmentAdjunctive treatmentGenital areaImmunomodulatory effectsPerigenital areaUlcer diseaseCimetidineCondylomaNo treatment